Literature DB >> 7725743

Multivariate analysis of risk factors influencing survival in 110 ethnic Chinese with papillary thyroid cancer.

T G Lorentz1, P W Lau, C Y Lo, W L Law, K Y Wan, I J Lauder.   

Abstract

Data from 110 Chinese patients presenting with papillary thyroid cancer to a single institution up to December 1985 have been analyzed to evaluate the possible risk factors affecting survival. There were 83 women and 27 men with an age range of 15 to 78 years (mean 45 years, median 42 years). The longest follow-up period is 39 years and the median 10 years. Cervical lymph node recurrence more than 6 months after surgery developed in 12 patients, of whom 1 died with a concomitant distant metastasis. "Thyroid bed" tumor recurrence, after apparently complete surgery, presented in 10 patients and resulted in 5 deaths. Distant metastases were identified in 17 patients with 7 deaths. Another 4 patients died from advanced local disease incompletely resectable on presentation. The following seven risk factors for survival were selected for multivariate analysis: age, sex, tumor size, histologic evidence of extrathyroidal spread, lymph node recurrence, neck recurrence, and distant metastases. Age, size, neck recurrence, and distant metastases were all significant on univariate analysis. Using Cox proportional hazards regression in the multivariate analysis of these seven factors, only age (p < 0.0001) was shown to be significant. Age over 40 years on first diagnosis was a highly significant indicator of high risk (p = 0.0003, log-rank).

Entities:  

Mesh:

Year:  1994        PMID: 7725743     DOI: 10.1007/bf00353761

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  15 in total

1.  Multivariate analysis of survival in differentiated thyroid cancer: the prognostic significance of the age factor.

Authors:  L J Schelfhout; C L Creutzberg; J F Hamming; G J Fleuren; D Smeenk; J Hermans; C J van de Velde; B M Goslings
Journal:  Eur J Cancer Clin Oncol       Date:  1988-02

2.  A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group.

Authors:  D P Byar; S B Green; P Dor; E D Williams; J Colon; H A van Gilse; M Mayer; R J Sylvester; M van Glabbeke
Journal:  Eur J Cancer       Date:  1979-08       Impact factor: 9.162

3.  Surgical treatment for thyroid cancer.

Authors:  O H Beahrs
Journal:  Br J Surg       Date:  1984-12       Impact factor: 6.939

4.  Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system.

Authors:  I D Hay; C S Grant; W F Taylor; W M McConahey
Journal:  Surgery       Date:  1987-12       Impact factor: 3.982

5.  Treatment of intrathyroidal papillary carcinoma of the thyroid.

Authors:  A L Vickery; C A Wang; A M Walker
Journal:  Cancer       Date:  1987-12-01       Impact factor: 6.860

6.  Changing clinical, pathologic, therapeutic, and survival patterns in differentiated thyroid carcinoma.

Authors:  B Cady; C E Sedgwick; W A Meissner; J R Bookwalter; V Romagosa; J Werber
Journal:  Ann Surg       Date:  1976-11       Impact factor: 12.969

7.  Is the EORTC prognostic index of thyroid cancer valid in differentiated thyroid carcinoma? Retrospective multivariate analysis of differentiated thyroid carcinoma with long follow-up.

Authors:  J Tennvall; A Biörklund; T Möller; J Ranstam; M Akerman
Journal:  Cancer       Date:  1986-04-01       Impact factor: 6.860

8.  Biologic considerations and operative strategy in papillary thyroid carcinoma: arguments against the routine performance of total thyroidectomy.

Authors:  K H Cohn; M Bäckdahl; G Forsslund; G Auer; A Zetterberg; G Lundell; P O Granberg; T Löwhagen; J S Willems; B Cady
Journal:  Surgery       Date:  1984-12       Impact factor: 3.982

9.  Multifactorial study of prognostic factors in differentiated thyroid carcinoma and a re-evaluation of the importance of age.

Authors:  F Bacourt; B Asselain; J C Savoie; E D'Hubert; J P Massin; G Doucet; A Leger; H Garnier
Journal:  Br J Surg       Date:  1986-04       Impact factor: 6.939

10.  Multifactorial analysis of survival in thyroid cancer. Pitfalls of applying the results of published studies to another population.

Authors:  P Hannequin; J C Liehn; M J Delisle
Journal:  Cancer       Date:  1986-10-15       Impact factor: 6.860

View more
  7 in total

Review 1.  Papillary carcinoma of thyroid: A 30-yr clinicopathological review of the histological variants.

Authors:  Alfred King-Yin Lam; Chung-Yau Lo; Karen Siu-Ling Lam
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

2.  Warthin tumor-like variant of papillary thyroid carcinoma: a case with dedifferentiation (anaplastic changes) and aggressive biological behavior.

Authors:  King Yin Lam; Chung Yau Lo; William I Wei
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

3.  Insular and anaplastic carcinoma of the thyroid: a 45-year comparative study at a single institution and a review of the significance of p53 and p21.

Authors:  K Y Lam; C Y Lo; K W Chan; K Y Wan
Journal:  Ann Surg       Date:  2000-03       Impact factor: 12.969

4.  Optimizing the treatment of AMES high-risk papillary thyroid carcinoma.

Authors:  Chung-Yau Lo; Wai-Fan Chan; King-Yin Lam; Koon-Yat Wan
Journal:  World J Surg       Date:  2004-11       Impact factor: 3.352

5.  Recurrent laryngeal nerve palsy in well-differentiated thyroid carcinoma: clinicopathologic features and outcome study.

Authors:  Wai-Fan Chan; Chung-Yau Lo; King-Yin Lam; Koon-Yat Wan
Journal:  World J Surg       Date:  2004-11       Impact factor: 3.352

6.  Mortality-related factors in 1056 radioiodine-treated patients with well-differentiated thyroid cancer in southern Thailand.

Authors:  Tada Yipintsoi; Teerapon Premprabha; Alan Geater; Tanyaluck Thientunyakij; Suchitra Thongmak
Journal:  World J Surg       Date:  2010-02       Impact factor: 3.352

7.  Staging systems for papillary thyroid carcinoma: a study of 2 tertiary referral centers.

Authors:  Brian Hung-Hin Lang; Sin-Ming Chow; Chung-Yau Lo; Stephen C K Law; King-Yin Lam
Journal:  Ann Surg       Date:  2007-07       Impact factor: 12.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.